NCT00216515View on ClinicalTrials.gov

The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type

PHASE4CompletedINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

November 30, 2005

Conditions

Alzheimer Disease

Interventions

DRUG

galantamine hydrobromide

All Listed Sponsors

lead

Janssen Korea, Ltd., Korea

INDUSTRY

NCT00216515 - The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type | Biotech Hunter | Biotech Hunter